Since the outbreak of COVID-19, the pharma industry has moved with unprecedented speed to progress vaccines through clinical trials safely, while simultaneously ramping up production on the chance of success.
As the world awaits news from these expedited clinical trials, however, we must also acknowledge that the task of vaccinating the world against COVID-19 won’t be easy – especially when it comes to bringing the public on side.
This paper uses Ipsos research to highlight the obstacles and opportunities that lie ahead – and the importance of building public support in determining any vaccine’s success.
Global vaccines research
As the race to develop a COVID-19 vaccine continues at speed, the world faces many more questions than answers – not only about when we might have a vaccine, but who will get it first, how will they get it and are they willing to have it? And how far will it take us on the journey back to ‘normal’…?
Market sizing and forecasting in the medical device & diagnostic markets
Understanding the market potential for a product is an integral part of any business plan. Assessing market size, identifying existing and new competitors – as well other drivers/constraints on growth – will inform and guide a business development plan and forecast.